Questions about whether Eli Lilly and Novo Nordisk can maintain their duopoly in weight loss drugs are fair game, but come “too soon,” one analyst said.
Communicating your story to the Street
Questions about whether Eli Lilly and Novo Nordisk can maintain their duopoly in weight loss drugs are fair game, but come “too soon,” one analyst said.